← FDA Drug Approvals (Drugs@FDA)

BENDAMUSTINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE · Approved 2022-12-07

Drug application

FDA Application #

ANDA205574

Application type

Abbreviated New Drug Application (Generic)

Brand name

BENDAMUSTINE HYDROCHLORIDE

Generic name

BENDAMUSTINE HYDROCHLORIDE

Active ingredients

BENDAMUSTINE HYDROCHLORIDE

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

ACCORD HLTHCARE

Manufacturer

Accord Healthcare, Inc.

First approval

2022-12-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown